Lowering a blood pressure (BP) in the management of cardiovascular diseases is known to be beneficial. However, the effects of the reduction in BP may have variable effects. These effects are based on multiple aspects such as baseline BP, comorbidities etc. A new meta-analysis published, states that the lowering of BP should be based on these risk factors rather than universal targets. Lowering a BP is the commonly followed intervention in the cardiovascular diseases.
The practice is well established with the known benefits to prevent cardiovascular diseases. It is a common practice to categorize the patients into continuously hypertensive and normal BP range. Various studies have showed that lowering systolic BP below 130 mmHg is beneficial in most patients. But, to what extent these effects differ by baseline blood pressure, a presence of comorbidities, or the drug class is less…
